Introduction : LUF is a form of anovulation and a subtle cause of female infertility. The syndrome cannot be diagnosed by traditional progesterone-dependent ovulation detection methods. Without the use of either transvaginal ultrasound (TVS) or laparoscopy as well as progesterone assay, LUF syndrome may go unnoticed. Objective : To assess the prevalence of LUF and the effect of stimulation protocol on its development as diagnosed by serial TVS and midluteal progesterone (MLP). Patients and Methods : A total of 300 cycles in 228 patients were monitored for various causes of infertility under different stimulation protocols: clomiphene citrare (CC)/HCG, or CC plus HMG/HCG, or HMG/HCG. Serial TVS was started from days -5 to days +5 (The day of HCG trigger of ovulation was cycle day zero). MLP was measured on day +7. TVS evidence of LUF was persistence of unruptured preovulatory follicle(s) up to day +5 together with bichemical evidence of luteinization (MLP > 1 ng/mL. Luteal phase length was measured to identify short luteal phase defect. Normal ovulatory cycle was diagnosed by TVS evidence of follicular rupture (visible corpus luteum with or without free fluid in DP) and biochemical evidence of good luteal function (MLP > lOng/ml) Luteal phase defect (LPD) was diagnosed by MLP<10 & >1 ng/ml. Results : Of the total 300 cycles in 228 patients, 16 cycles in 15 patients were diagnosed as LUF giving a prevalence of 9% of cycles. Mean MLP was significantly lower in LUF cycles compared to normal ovulatory cycles (9.1±5.9 vs 21.9+1212 ng/mL respectively) (P<0.001). CC/HCG protocol was used in 48% of LUF cycles compared to 18.6% of normal cycles (P<0.001), while CC plus HMG/HCG or HMG/HCG were used in (40%, 36.9% in LUF and, normal ovulatory cycles respectively) (P=0.07). The percentage of PCOD cases was not significantly different in both groups (40% & 31% in LUF & normal ovulatroy cycles respectively). Although CC stimulation was used in 154/228 first cycles (35%) and 49/70 repeat cycles (35%), only 2 cases had recurrent LUF in first and repeat cycles of same patients. Although mean luteal phase length was not significanlty different (14.3±2.5 days vs 15.7+2.5) days in LUF and normal cycles respectively), 60% of LUF cases had MLP < 10 ng/ml (compared to none of the normal control. Cycle pregnancy rate was 21% in the normal cycles and zero in LUF cycles.
INTRODUCTION
Luteinized unruptured follicle (LUF) syndrome is defined as failure of ovulation in which despite the absence of follicular rupture and release of the oocyte, the unruptured follicle undergoes luteinization under the action of L.H. In such cases normal production of progesterone and duration of the luteal phase of the cycle could be seen " .
LUF is found in 4.9-10% of menstrual cycles of normal fertile women ^ " . A higher incidence has been reported in infertile women ^ . The range is between < 5% to about 20% of stimulated cycles ■ .
The occurrence of LUF has been linked to many conditions, such as unexplained infertility, endometriosis, pelvic adhesions and the use of nonsteroidal anti-inflammatory, drugs (NSAIDs) (1, (8) (9) (10) (11) (12) (13) (14) The implication of the syndrome to infertility problem ranges from being an infrequent, sporadic phenomena and an uncommon cause of infertility in regularly cycling infertile women^ ' to a recurrent phenomena in about one third of cases ^ '.
The incidence of LUF in stimulated cycles was reported to be 31.8% by Zhu (1989) (16) and 63% of LUF patients had recurrences and that LUF syndrome is of particular importance in unexplained infertility.
However, to our knowledge, no extensive studies were found on the prevalence of LUF in stimulated anovulatory and superovulatcd ovulatory infertile women, nor studies on the influence of stimulation protocol on the incidence of LUF.
The aim of the present study was to determine the prevalence of LUF among infertile women and the effect of stimulation protocol on its development. 
PATIENTS & METHODS

RESULTS
As shown in Table (I) 228 cases underwent 300 cycle monitoring giving average cycle number of 1.3% per patient. Although 76% of cycles were non-repeat (Table II) , the remaining cycles were repeated ranging from 2 to 5 times. The indication for monitoring was infertility in most of cases. As seen in Although CC/HCG was used in nearly similar ratios of repeat and non repeat cycles (Table VII) LUF recurred only in 2 cycles in same patient giving recurrence rate of 2.8% of LUF cycles. Although LUF is found in 4.9-10% of menstrual cycles of normal fertile women ^ a higher incidence has been reported in infertile women and ranges AD between 5 to 23% of stimulated cycles The incidence of LUF in the present study was found to be 9% (Table V) 
' where the incidence o( LUF were only 6.7% and 6% respectively.
The variabilities in the prevalence of LUF in most studies could be due to differences in the subjects studied and he variabilities of their infertility status and/or to the differences in stimulation protocols. Koninckx and Brosens (1982) (9) concluded that LUF occur more frequently in cases of unexplained infcrility. Luciano and associates (1990) " J . (23) reported that 20% ol patients treated with clomiphene citrate (CC) had LUF.
Baleman et al. (1990)
In the present study, the prevalence of LUF varied according to the stimulation protocol (Table V) . (24 27) of LUF by central or local actions
The incidence of LUF with HMG/HCG stimulation was very low (0.1%) ( Table V) In the present study, although PCOS accounted for 87% of the studied cases (Table III) (32) found that not only antimullerian hormone level, but also obesity, insulin resistance and/or elevated androgen level may relate to the development of PCOS. In the present study the BMI showed insignificant difference between cases with and those without LUF cases (Table VI) .
In the present work, the mean MLP was significantly lower in LUF compared to normal 
